J&J shuts down a massive R&D facility,located in Bay Area, less than 18 months after opening it
BI's liver scarring treatment has shown improvementsin disease activity in a phase 2 trial
GSK's first UTI treatment, gepotidacin,has demonstrated efficacy in treating gonorrhea as well
AbbVie invests in global rights to a novel approach for chronic inflammation
Pfizer aims to invest in oncology after COVID decline
Pfizer's vaccine, Abrysvo, maintains efficacy through 2nd RSV season
Takeda eliminates drug candidates from its oncology pipeline
Vivani's weight loss treatment, works as well as Novo Nordisk's Ozempic in mice
J.P. Morgan shows interest in companies developing psychedelic therapies for mental health
The CDC issues a warning about a potential shortage of tetanus shots
Biocon Biologics secures US market entry for a proposed biosimilar to J&J'S Stelara
Senators urge FDA to address the misleading content used in Pharma ads
%402x.svg){kind=icon}
.png)
%402x.svg){kind=icon}
